Search
Proteomics managing director Richard Lipscombe.

WA science firm in China deal

Nedlands company Proteomics International Laboratories is hoping for increased support for its initial public offering after finalising an agreement with a Chinese drug development business.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 30/11/18

1 year TSR5 year TSR
thData Exchange Network
24thProteomics International Laboratories167%
248thMejority Capital5%-8%
663rdOBJ-53%-10%
723rdMyFiziq-61%
741 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

16/04/18
$0 Other
16/04/18
$0 Other
06/04/18
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

129th↓Proteomics International Laboratories$2.1m
131st↑MyFiziq$2.1m
132nd↓Mejority Capital$2.1m
134th-Data Exchange Network$2.0m
135th↓OBJ$2.0m
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer